XERIS PHARMACEUTICALS INC

CUSIP: 98422L107 Class: COM

Redmile Group, LLC's Holding History (CIK: 0001425738)

Note: Option positions (PUT/CALL) are excluded.

Q3 2021
Shares 1,358,825 Value ($000) $3,329 Avg Close — Range —
Q2 2021
Shares 1,358,825 Value ($000) $5,530 Avg Close — Range —
Q1 2021
Shares 1,712,304 Value ($000) $7,722 Avg Close — Range —
Q4 2020
Shares 2,397,441 Value ($000) $11,795 Avg Close — Range —
Q3 2020
Shares 2,397,441 Value ($000) $14,217 Avg Close — Range —
Q2 2020
Shares 2,397,441 Value ($000) $6,377 Avg Close — Range —
Q1 2020
Shares 2,957,441 Value ($000) $5,767 Avg Close — Range —
Q4 2019
Shares 3,000,641 Value ($000) $21,155 Avg Close — Range —
Q3 2019
Shares 3,000,641 Value ($000) $29,496 Avg Close — Range —
Q2 2019
Shares 3,000,641 Value ($000) $34,327 Avg Close — Range —
Q1 2019
Shares 3,000,641 Value ($000) $30,126 Avg Close — Range —
Q4 2018
Shares 2,412,641 Value ($000) $41,015 Avg Close — Range —
Q3 2018
Shares 2,412,640 Value ($000) $42,414 Avg Close — Range —
Q2 2018
Shares 2,412,642 Value ($000) $45,792 Avg Close — Range —